| Title： | Clinical Practice Guideline for Clinical Application of Biosimilars |
| Edition： | Original |
| Classification： | Standard guideline |
| Field： | Comprehensive guideline |
| Countries and regions： | China |
| Guidelines users： | |
| Evidence classification method： | The Grading of Recommendations Assessment, Development and Evaluation （GRADE） |
| Development unit： | Peking University Third Hospital |
| Registration time: | 2020-11-04 |
| Registration number： | IPGRP-2020CN172 |
| Purpose of the guideline: |
Latest registration
